Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development
Authors:
- Ting- Hui- LinTLTing- Hui- Lin
- Chun-Yang LinChun-Yang Lin
- Min-Shi LeeMin-Shi Lee
- 1 March 2019
- Vol. 37 (13) , 1897-1903
Abstract
No abstract availableKeywords
Funding Information
- National Health Research Institutes
- Ministry of Science and Technology, Taiwan (106-3114-Y404-002)
This publication has 50 references indexed in Scilit:
- The first case of H7N9 influenza in TaiwanThe Lancet, 2013
- Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stabilityBMC Biotechnology, 2012
- Structure and Receptor Complexes of the Hemagglutinin from a Highly Pathogenic H7N7 Influenza VirusJournal of Virology, 2012
- Recombinant Trimeric HA Protein Immunogenicity of H5N1 Avian Influenza Viruses and Their Combined Use with Inactivated or Adenovirus VaccinesPLOS ONE, 2011
- Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemicNature, 2009
- FluBlok, a next generation influenza vaccine manufactured in insect cellsBiologicals, 2009
- Comparative Efficacy of Neutralizing Antibodies Elicited by Recombinant Hemagglutinin Proteins from Avian H5N1 Influenza VirusJournal of Virology, 2008
- Influenza Virus Hemagglutinin (H3 Subtype) Requires Palmitoylation of Its Cytoplasmic Tail for Assembly: M1 Proteins of Two Subtypes Differ in Their Ability To Support AssemblyJournal of Virology, 2005
- Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusionProceedings of the National Academy of Sciences, 2003
- Stabilization of short collagen-like triple helices by protein engineeringJournal of Molecular Biology, 2001